Repros Therapeutics Inc (RPRX)

[docbanker]

I think the probability has never really changed over the last 6 months or so.
I believe 60-70% chance, only T - different mechanism of action and maintenance of LH/FSH is a huge plus
20-30% T plus libido/distress (thus requires more rigorous studies with more prescreening)
5%ish no clear clinical pathway, i.e. we don't know what you should measure

I believe the combination of poor outcomes for binomial events recently, a poor biotech tape and shaky markets have tilted the probabilities in some peoples' minds to far worse. The stock was just at $15! Proellex is as de-risked as it has ever been.